Statistics
Total Visits
| Views | |
|---|---|
| Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period | 116 |
Total Visits Per Month
| August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period | 0 | 0 | 0 | 2 | 3 | 2 | 0 | 3 | 3 | 3 | 2 |
File Visits
| Views | |
|---|---|
| Brbaum_Subctnous.pdf | 140 |
| Brbaum_Subctnous_Suppl.pdf | 18 |
Top country views
| Views | |
|---|---|
| United States | 41 |
| Sweden | 39 |
| Ukraine | 8 |
| Germany | 7 |
| United Kingdom | 6 |
| Ireland | 4 |
| Armenia | 1 |
| Australia | 1 |
| Finland | 1 |
| Netherlands | 1 |
Top cities views
| Views | |
|---|---|
| Ashburn | 7 |
| Fairfield | 7 |
| Mountain View | 7 |
| Dublin | 4 |
| San Diego | 3 |
| Cambridge | 2 |
| Jacksonville | 2 |
| Seattle | 2 |
| Ann Arbor | 1 |
| Boardman | 1 |
